234 related articles for article (PubMed ID: 34880055)
21. Safety and effectiveness of nurse telephone consultation in out of hours primary care: randomised controlled trial. The South Wiltshire Out of Hours Project (SWOOP) Group.
Lattimer V; George S; Thompson F; Thomas E; Mullee M; Turnbull J; Smith H; Moore M; Bond H; Glasper A
BMJ; 1998 Oct; 317(7165):1054-9. PubMed ID: 9774295
[TBL] [Abstract][Full Text] [Related]
22. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
[TBL] [Abstract][Full Text] [Related]
23. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
[TBL] [Abstract][Full Text] [Related]
24. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
Kornblith AB; Lan L; Archer L; Partridge A; Kimmick G; Hudis C; Winer E; Casey R; Bennett S; Cohen HJ; Muss HB
J Clin Oncol; 2011 Mar; 29(8):1022-8. PubMed ID: 21300923
[TBL] [Abstract][Full Text] [Related]
25. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada.
Habbous S; Tai X; Beca JM; Arias J; Raphael MJ; Parmar A; Crespo A; Cheung MC; Eisen A; Eskander A; Singh S; Trudeau M; Gavura S; Dai WF; Irish J; Krzyzanowska M; Lapointe-Shaw L; Naipaul R; Peacock S; Yeung L; Forbes L; Chan KKW
JAMA Netw Open; 2022 Aug; 5(8):e2225118. PubMed ID: 35917122
[TBL] [Abstract][Full Text] [Related]
27. Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.
Enright K; Grunfeld E; Yun L; Moineddin R; Ghannam M; Dent S; Eisen A; Trudeau M; Kaizer L; Earle C; Krzyzanowska MK
J Oncol Pract; 2015 Mar; 11(2):126-32. PubMed ID: 25604597
[TBL] [Abstract][Full Text] [Related]
28. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
29. Feasibility randomised controlled trial of remote symptom chemotherapy toxicity monitoring using the Canadian adapted Advanced Symptom Management System (ASyMS-Can): a study protocol.
Moradian S; Krzyzanowska M; Maguire R; Kukreti V; Amir E; Morita PP; Liu G; Howell D
BMJ Open; 2020 Jun; 10(6):e035648. PubMed ID: 32554724
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
van Ramshorst MS; van der Voort A; van Werkhoven ED; Mandjes IA; Kemper I; Dezentjé VO; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS;
Lancet Oncol; 2018 Dec; 19(12):1630-1640. PubMed ID: 30413379
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial.
Molassiotis A; Russell W; Hughes J; Breckons M; Lloyd-Williams M; Richardson J; Hulme C; Brearley S; Campbell M; Garrow A; Ryder W
Health Technol Assess; 2013 Jun; 17(26):1-114. PubMed ID: 23803562
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
33. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
[TBL] [Abstract][Full Text] [Related]
34. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Chan A; Delaloge S; Holmes FA; Moy B; Iwata H; Harvey VJ; Robert NJ; Silovski T; Gokmen E; von Minckwitz G; Ejlertsen B; Chia SKL; Mansi J; Barrios CH; Gnant M; Buyse M; Gore I; Smith J; Harker G; Masuda N; Petrakova K; Zotano AG; Iannotti N; Rodriguez G; Tassone P; Wong A; Bryce R; Ye Y; Yao B; Martin M;
Lancet Oncol; 2016 Mar; 17(3):367-377. PubMed ID: 26874901
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
[TBL] [Abstract][Full Text] [Related]
36. Emergency Medicine Palliative Care Access (EMPallA): protocol for a multicentre randomised controlled trial comparing the effectiveness of specialty outpatient versus nurse-led telephonic palliative care of older adults with advanced illness.
Grudzen CR; Shim DJ; Schmucker AM; Cho J; Goldfeld KS;
BMJ Open; 2019 Jan; 9(1):e025692. PubMed ID: 30813112
[TBL] [Abstract][Full Text] [Related]
37. A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.
Salisbury C; Foster NE; Hopper C; Bishop A; Hollinghurst S; Coast J; Kaur S; Pearson J; Franchini A; Hall J; Grove S; Calnan M; Busby J; Montgomery AA
Health Technol Assess; 2013 Jan; 17(2):1-157, v-vi. PubMed ID: 23356839
[TBL] [Abstract][Full Text] [Related]
38. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE
Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875
[TBL] [Abstract][Full Text] [Related]
39. A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study.
Hale TM; Jethwani K; Kandola MS; Saldana F; Kvedar JC
J Med Internet Res; 2016 Apr; 18(5):e91. PubMed ID: 27154462
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
